Pardes Biosciences, Inc. Stock
Equities
PRDS
US69945Q1058
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 17 M€ | +5.97% | - |
1st Jan change | Capi. | |
---|---|---|
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |